Article
Gastroenterology & Hepatology
Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
Summary: Through retrospective review of 121 Korean patients with SR-ASUC, it was found that there were no significant differences in the rates of treatment failure and colectomy at 3 months between the CsA and IFX treatment groups. Additionally, prior use of azathioprine and Mayo score at the time of rescue therapy were both associated with treatment failure or colectomy within 3 months.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Article
Gastroenterology & Hepatology
Gaurav Syal, Lori Robbins, Amir Kashani, Nirupama Bonthala, Edward Feldman, Phillip Fleshner, Eric Vasiliauskas, Dermot McGovern, Christina Ha, Stephan Targan, Gil Y. Melmed
Summary: Serum albumin and band neutrophil percentage are independent predictors of failure of infliximab rescue therapy in patients with acute severe ulcerative colitis. The combination of serum albumin <= 2.5 g/dl and band neutrophil count >= 13% has a 100% positive predictive value for 90-day colectomy.
DIGESTIVE DISEASES AND SCIENCES
(2021)
Article
Medicine, General & Internal
Elena De Cristofaro, Silvia Salvatori, Irene Marafini, Francesca Zorzi, Norma Alfieri, Martina Musumeci, Emma Calabrese, Giovanni Monteleone
Summary: This retrospective study examined the long-term risk and predictors of colectomy in ASUC patients responding to IVCS or IFX. The results showed that a low serum albumin level and colonic dilation were risk factors for long-term colectomy in these patients.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Gastroenterology & Hepatology
Jeffrey A. Berinstein, Jessica L. Sheehan, Michael Dias, Elliot M. Berinstein, Calen A. Steiner, Laura A. Johnson, Randolph E. Regal, John I. Allen, Kelly C. Cushing, Ryan W. Stidham, Shrinivas Bishu, Jami A. R. Kinnucan, Shirley A. Cohen-Mekelburg, Akbar K. Waljee, Peter D. R. Higgins
Summary: The study suggests that tofacitinib with concomitant intravenous corticosteroids may reduce the risk of colectomy in ASUC patients, especially with a dosage of 10 mg three times daily. Rates of complications and steroid dependence were similar between the tofacitinib group and controls. Prospective trials are needed to further investigate the safety and optimal dosing of tofacitinib in ASUC patients.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Article
Gastroenterology & Hepatology
Atsushi Kohyama, Kazuhiro Watanabe, Akira Sugita, Kitaro Futami, Hiroki Ikeuchi, Ken-ichi Takahashi, Yasuo Suzuki, Kouhei Fukushima
Summary: This study defined and investigated postoperative ulcerative colitis-related severe enteritis (UCRSE), with 0.8% of cases meeting the criteria. Major symptoms included massive intestinal bleeding, high-output stoma, and intestinal perforation. Some patients developed serious complications, required surgery or long-term maintenance therapy.
JOURNAL OF GASTROENTEROLOGY
(2021)
Review
Pharmacology & Pharmacy
Alix Demaris, Ella S. K. Widigson, Johan F. K. F. Ilvemark, Casper Steenholdt, Jakob B. Seidelin, Wilhelm Huisinga, Robin Michelet, Linda B. S. Aulin, Charlotte Kloft
Summary: This review aims to analyze the population PK models of infliximab (IFX) in patients with ulcerative colitis (UC) and acute severe UC (ASUC), and assess the impact of disease activity on IFX PK. The results showed that there are still many gaps in the current research, such as a limited number of models specifically developed for UC patients, a lack of studies on severe UC patients, and a lack of evaluation of predictive performance for the models. Therefore, more comprehensive research and adequate reporting and evaluation of the models are needed for clinical application.
Review
Medicine, General & Internal
Benjamin L. Gordon, Robert Battat
Summary: Therapeutic drug monitoring (TDM) is a useful strategy in ulcerative colitis (UC), particularly in acute severe UC (ASUC). While there is limited data available for the use of TDM of infliximab in ASUC, observational data suggest that higher serum infliximab concentrations and lower clearance are associated with better clinical outcomes and decreased rates of colectomy. However, more studies are needed to evaluate optimal dosing and TDM targets in this population.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Gastroenterology & Hepatology
Robert Gilmore, Wei Lian Tan, Richard Fernandes, Yoon-Kyo An, Jakob Begun
Summary: This study found that upadacitinib may be a safe and effective salvage therapy for patients with steroid-refractory acute severe ulcerative colitis who have previously failed to respond to infliximab therapy. Prospective studies are needed to determine the safety and efficacy of upadacitinib use in this setting before routine use can be recommended.
JOURNAL OF CROHNS & COLITIS
(2023)
Article
Gastroenterology & Hepatology
Maia Kayal, Hannah Posner, Hadar Meringer Milwidsky, Michael Plietz, Sergey Khaitov, Patricia Sylla, Alexander Greenstein, Marla C. Dubinsky, Saurabh Mehandru, Jean Frederic Colombel
Summary: A retrospective cohort analysis of 416 patients found that acute severe ulcerative colitis was significantly associated with subsequent acute pouchitis. The risk of pouchitis may be influenced by immune activation and disease severity prior to colectomy.
INFLAMMATORY BOWEL DISEASES
(2023)
Article
Gastroenterology & Hepatology
Lori A. Zimmerman, Jonathan Spaan, Nathan Weinbren, Krishanth Manokaran, Aravindh Ajithkumar, Anna Bogursky, Enju Liu, Craig Lillehei, Brent R. Weil, Jill M. Zalieckas, Athos Bousvaros, Paul A. Rufo
Summary: This study retrospectively analyzed the outcomes of 170 pediatric patients with acute severe colitis (ASC) who were treated with either IFX or TAC after failing intravenous corticosteroids. The study found that there were no significant differences in the likelihood of colectomy 6 months after initiating IFX or TAC rescue therapy, and the efficacy of both agents was comparable. However, the types of adverse effects differed between the two therapies. These data support the use of either TAC or IFX in children with ASC refractory to intravenous corticosteroids.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
(2023)
Article
Gastroenterology & Hepatology
Abhishek Bhurwal, Carlos D. Minacapelli, Anish Patel, Hemant Mutneja, Akshay Goel, Ishani Shah, Vikas Bansal, Bhaumik Brahmbhatt, Kiron M. Das
Summary: This study revealed racial and geographical disparities in colectomy rates among hospitalized patients with UC after the introduction of anti-TNF therapy. African American and Hispanic patients had significantly lower colectomy rates compared to White patients, while the western regions of the United States had the highest colectomy rates. Further research is needed to understand the underlying social and biological factors contributing to these disparities.
INFLAMMATORY BOWEL DISEASES
(2022)
Article
Gastroenterology & Hepatology
David Laharie, Arnaud Bourreille, Julien Branche, Matthieu Allez, Yoram Bouhnik, Jerome Filippi, Frank Zerbib, Guillaume Savoye, Lucine Vuitton, Jacques Moreau, Aurelien Amiot, Laurent Beaugerie, Elena Ricart, Olivier Dewit, Antonio Lopez-Sanroman, Mathurin Fumery, Franck Carbonnel, Anthony Buisson, Benoit Coffin, Xavier Roblin, Gert van Assche, Maria Esteve, Martti Farkkila, Javier P. Gisbert, Philippe Marteau, Stephane Nahon, Martine de Vos, Laurent Peyrin-Biroulet, Jean-Yves Mary
Summary: In patients with steroid-refractory ASUC responding to second-line medical therapy, the process of endoscopic remission started with bleeding remission and was not achieved in half the patients at day 98 for vascular pattern. Infliximab provided a higher endoscopic remission rate than cyclosporine at day 98.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Article
Gastroenterology & Hepatology
Robert Gilmore, Patrick Hilley, Ashish Srinivasan, Matthew Choy, Peter De Cruz
Summary: This study found that high-dose tofacitinib may have a role as salvage therapy in patients with steroid-refractory ASUC.
JOURNAL OF CROHNS & COLITIS
(2022)
Article
Medicine, General & Internal
Myriam Renaud, Ahmet Ayav, Benedicte Caron, Laurent Peyrin-Biroulet, Adeline Germain
Summary: This retrospective study investigated the safety and feasibility of Hartmann's pouch surgery in the treatment of patients with acute severe ulcerative colitis. The results showed that Hartmann's pouch surgery has low rates of complications and pelvic sepsis, and can successfully restore intestinal continuity.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Medicine, General & Internal
Nicholas Clark, Michael MacIsaac, Robert Little, Sara Vogrin, Maria Harrison, Thomas Tiang, James Keck, Michael Johnston, Georgina Cunningham, Emily Wright, William Connell
Summary: In this study, the authors aimed to evaluate the effect of changing from CsA to IFX for the treatment of steroid-refractory ASUC on colectomy rates. A retrospective review was conducted on two cohorts, and it was found that there was no significant difference in colectomy rates between IFX and CsA treatment at 30 days, 6 months, and 12 months.
INTERNAL MEDICINE JOURNAL
(2023)
Editorial Material
Gastroenterology & Hepatology
Marco Bianchi, Valeria Clemente, Maurizio Koch
DIGESTIVE AND LIVER DISEASE
(2015)
Article
Gastroenterology & Hepatology
Maurizio Koch
JOURNAL OF CLINICAL GASTROENTEROLOGY
(2016)
Article
Gastroenterology & Hepatology
Manuela Mangone, Alessandra Moretti, Federica Alivernini, Claudio Papi, Ruggero Orefice, Angelo Dezi, Emanuela Amadei, Annalisa Aratari, Marco Bianchi, Valentina Tornatore, Maurizio Koch
DIGESTIVE AND LIVER DISEASE
(2012)
Letter
Gastroenterology & Hepatology
Francesca Chiesara, Annalisa SpagnoloMaurizio, Maurizio Koch, Alessandra Moretti
DIGESTIVE AND LIVER DISEASE
(2014)
Article
Gastroenterology & Hepatology
Floriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, Maria Masocco, Alfonso Mele, Carmine Coppola, Michele Milella, Guglielmo Borgia, Pietro Andreone, Maurizio Koch, Anna Linda Zignego, Mario Romano, Maurizio Carrara, Piero Luigi Almasio, Emilio Azzola, Gerardo Nardone, Antonio Benedetti, Giampiero Carosi, Francesco Mazzotta, Evangelista Sagnelli, Mario Rizzetto
DIGESTIVE AND LIVER DISEASE
(2014)
Article
Gastroenterology & Hepatology
Gianluca Rotondano, Livio Cipolletta, Maurizio Koch, Maria Antonia Bianco, Enzo Grossi, Riccardo Marmo
DIGESTIVE AND LIVER DISEASE
(2014)
Article
Gastroenterology & Hepatology
Riccardo Marmo, Mario Del Piano, Gianluca Rotondano, Maurizio Koch, Maria Antonia Bianco, Alessandro Zambelli, Giovanni Di Matteo, Enzo Grossi, Livio Cipolletta
GASTROINTESTINAL ENDOSCOPY
(2012)
Article
Gastroenterology & Hepatology
Riccardo Marmo, Maurizio Koch, Livio Cipolletta, Maria Antonia Bianco, Enzo Grossi, Gianluca Rotondano
GASTROINTESTINAL ENDOSCOPY
(2014)
Article
Gastroenterology & Hepatology
Maurizio Koch
JOURNAL OF CLINICAL GASTROENTEROLOGY
(2018)
Article
Gastroenterology & Hepatology
S. Bruno, S. Bollani, A. L. Zignego, J. M. Pascasio, C. Magni, A. Ciancio, M. Caremani, A. Mangia, S. Marenco, S. Piovesan, L. Chemello, S. Babudieri, A. Moretti, F. Gea, C. Colletta, R. Perez-Alvarez, X. Forns, J. R. Larrubia, J. Arenas, J. Crespo, V. Calvaruso, F. Ceccherini Silberstein, P. Maisonneuve, A. Craxi, J. L. Calleja
JOURNAL OF VIRAL HEPATITIS
(2015)
Letter
Gastroenterology & Hepatology
Maurizio Koch, Lucio Capurso
Article
Gastroenterology & Hepatology
F. S. Mennini, P. Sciattella, A. Marcellusi, B. Toraldo, M. Koch
DIGESTIVE AND LIVER DISEASE
(2017)
Article
Pharmacology & Pharmacy
V. Festa, S. Spila Alegiani, F. Chiesara, A. Moretti, M. Bianchi, A. Dezi, G. Traversa, M. Koch
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
(2017)
Article
Gastroenterology & Hepatology
Virginia Festa, Angelo Andriulli, Maria Rosaria Valvano, Generoso Uomo, Francesco Perri, Nicola Andriulli, Salvatore Corrao, Nicola Andriulli, Salvatore Corrao, Maurizio Koch
JOURNAL OF THE PANCREAS
(2013)
Review
Medicine, General & Internal
A. Moretti, A. Spagnolo, M. Mangone, F. Chiesara, A. Aratari, C. Papi, M. Koch
CLINICA TERAPEUTICA
(2012)